Internal Medicine · Mobile, AL
NPI
1346248358
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
101 Memorial Hospital Dr, Ste 200
Mobile, AL, 36608
Phone (251) 414-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$224K
7,850 services
Medicare patients, 2024
439
Average age 75
Drug cost, 2024
$4.0M
29,727 prescriptions
Company payments, 2025
$3,474
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward G Carlos was code J0897 (injection, denosumab, 1 mg), 1,380 times for 13 patients. In total Edward G Carlos billed 7,850 services in 125 codes, and Medicare paid $224K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 13 | $20.20 | $28K |
| 99214 Office E&M - Established | Office | 953 | 282 | $78.32 | $75K |
| 36415 Venipuncture Blood Collection | Office | 674 | 270 | $5.88 | $3,963 |
| 85025 Blood Count | Office | 395 | 253 | $7.57 | $2,991 |
| 80053 Clinical Chemistry | Office | 372 | 251 | $10.26 | $3,816 |
| 82550 Clinical Chemistry | Office | 286 | 225 | $6.37 | $1,822 |
| 80048 Clinical Chemistry | Office | 260 | 152 | $8.24 | $2,141 |
| 99232 Hospital E&M - Subsequent | Facility | 204 | 89 | $53.56 | $11K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 202 | 202 | $117.40 | $24K |
| 83036 Blood Count | Office | 197 | 95 | $9.44 | $1,859 |
| 80061 Clinical Chemistry | Office | 168 | 158 | $12.97 | $2,180 |
| 84443 Clinical Chemistry | Office | 125 | 95 | $16.34 | $2,043 |
| 96372 Injection Administration | Office | 122 | 63 | $9.43 | $1,151 |
| 99223 Hospital E&M - Initial | Facility | 110 | 107 | $116.01 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 104 | 26 | $0.78 | $80.73 |
By year: 2022 $272K for 8,472 services; 2023 $243K for 7,799 services; 2024 $224K for 7,850 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 674 | 270 | $5.88 | $3,963 |
| 85025 Blood Count | 395 | 253 | $7.57 | $2,991 |
| 80053 Clinical Chemistry | 372 | 251 | $10.26 | $3,816 |
| 82550 Clinical Chemistry | 286 | 225 | $6.37 | $1,822 |
| 80048 Clinical Chemistry | 260 | 152 | $8.24 | $2,141 |
| 83036 Blood Count | 197 | 95 | $9.44 | $1,859 |
| 80061 Clinical Chemistry | 168 | 158 | $12.97 | $2,180 |
| 84443 Clinical Chemistry | 125 | 95 | $16.34 | $2,043 |
| 83721 Clinical Chemistry | 90 | 90 | $10.29 | $926 |
| 84439 Clinical Chemistry | 77 | 52 | $8.74 | $673 |
Medicare prescription drug claims, 2024
In 2024, the drug Edward G Carlos prescribed most often to Medicare patients was Amlodipine Besylate, with 1,528 prescriptions and refills. In total Edward G Carlos wrote 29,727 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,528 | 4,336 | 468 | $9,090 |
| Rosuvastatin Calcium Generic | 1,302 | 3,688 | 398 | $18K |
| Olmesartan Medoxomil Generic | 1,165 | 3,366 | 359 | $23K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,139 | 1,139 | 188 | $15K |
| Omeprazole Generic | 1,110 | 3,109 | 370 | $23K |
| Atorvastatin Calcium Generic | 975 | 2,730 | 294 | $10K |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 801 | 2,278 | 249 | $4,622 |
| Bisoprolol Fumarate Generic | 735 | 2,053 | 215 | $23K |
| Hydralazine Hcl Generic | 731 | 1,996 | 256 | $13K |
| Furosemide Generic | 703 | 1,854 | 235 | $3,506 |
| Ezetimibe Generic | 676 | 1,899 | 207 | $11K |
| Levothyroxine Sodium Generic | 599 | 1,687 | 157 | $6,000 |
| Losartan Potassium Generic | 575 | 1,642 | 181 | $6,031 |
| Meloxicam Generic | 527 | 1,260 | 196 | $2,552 |
| Potassium Chloride Generic | 512 | 1,442 | 172 | $8,828 |
Brand drugs: 4,596 claims; generic drugs: 24,901 claims; opioid claims: 1,454.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward G Carlos $3,474 ($3,474 in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $995.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 30 | $995 |
| Novo Nordisk Inc NVO | 23 | $355 |
| Amgen Inc. AMGN | 42 | $281 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 18 | $243 |
| Lilly USA, LLC LLY | 12 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $184 |
| Sumitomo Pharma America, Inc. 4506.T | 17 | $170 |
| Medtronic, Inc. MDT | 14 | $149 |
| Xeris Pharmaceuticals, Inc. | 7 | $129 |
| Exact Sciences Corporation EXAS | 5 | $88.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.